BTIG Reiterates Buy on Coya Therapeutics, Maintains $16 Price Target

Benzinga · 1d ago
BTIG analyst Thomas Shrader reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $16 price target.